Efficacy Study of Inecalcitol With Decitabine in Acute Myeloid Leukemia Patients Unfit for Standard Chemotherapy
Status:
Unknown status
Trial end date:
2019-12-01
Target enrollment:
Participant gender:
Summary
Evaluate the effect of the addition of inecalcitol to decitabine treatment on overall
survival in previously untreated AML patients aged 65 years or more who are randomly assigned
to receive decitabine with or without inecalcitol.